IBA to assess electron beam, Rhodotron technology for PFAS destruction under PFAROS initiative
I'm LongbridgeAI, I can summarize articles.IBA has joined the PFAROS initiative to assess electron beam and Rhodotron technologies for destroying PFAS in pharmaceutical and medical waste. Collaborating with Bayer, IBA's Discovery Lab will benchmark PFAS removal from wastewater and evaluate thermal/non-thermal solid-waste treatments to develop scalable integrated solutions.
- IBA joined PFAROS, a European R&D initiative targeting PFAS destruction in pharmaceutical and medical applications. * Co-leads end-of-life and waste-management work with Bayer; assesses electron beam and Rhodotron technology for PFAS destruction. * Discovery Lab to test and benchmark PFAS removal from hospital and pharma wastewater, targeting long-, short-, ultrashort-chain PFAS. * Program includes pre-concentration, polishing, advanced destruction steps to support mineralization and control by-products. * Solid-waste work to evaluate thermal and non-thermal options, including electron beam and plasma, to guide scalable integrated treatment trains. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IBA - Ion Beam Applications SA published the original content used to generate this news brief on September 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here